injectable drugs

WuXi STA Opens new Parenteral Formulation Line

WuXi STA has started up a new parenteral formulation line at its drug product site in Wuxi City, China. The company’s second line for parenteral drug product clinical and commercial manufacturing to go on stream this year has an annual capacity of 10 million units.

Pfizer Gets Green Light for Hospira Acquisition

Fresenius May Lift Outlook Again on Rivals' Shortages

U.S. Health Advisers Back Two New Eye Treatments

Small Generic Drug Firms Need Niches to Survive Looming Price War